Forssell-Aronsson E - Search Results

1

Transcriptional effects of ¹⁷⁷Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice.

Spetz J, Langen B, Rudqvist NP, Parris TZ, Shubbar E, Dalmo J, Wängberg B, Nilsson O, Helou K, Forssell-Aronsson E. Spetz J, et al. EJNMMI Res. 2019 Mar 20;9(1):28. doi: 10.1186/s13550-019-0500-2. EJNMMI Res. 2019. PMID: 30895393 Free PMC article.

2

Somatostatin receptors on neuroendocrine tumors--a way to intraoperative diagnosis and localization.

Ahlman H, Tisell LE, Wängberg B, Nilsson O, Fjälling M, Forssell-Aronsson E. Ahlman H, et al. Yale J Biol Med. 1994 May-Aug;67(3-4):215-21. Yale J Biol Med. 1994. PMID: 7502530 Free PMC article.

3

Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide.

Forssell-Aronsson E, Fjälling M, Nilsson O, Tisell LE, Wängberg B, Ahlman H. Forssell-Aronsson E, et al. J Nucl Med. 1995 Jan;36(1):7-12. J Nucl Med. 1995. PMID: 7799086 Free article.

4

Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumours and evaluation of intraoperative scintillation detection.

Ahlman H, Wängberg B, Tisell LE, Nilsson O, Fjälling M, Forssell-Aronsson E. Ahlman H, et al. Br J Surg. 1994 Aug;81(8):1144-9. doi: 10.1002/bjs.1800810820. Br J Surg. 1994. PMID: 7953343

5

Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector.

Ahlman H, Tisell LE, Wängberg B, Nilsson O, Forssell-Aronsson E, Fjälling M. Ahlman H, et al. Semin Oncol. 1994 Oct;21(5 Suppl 13):21-8. Semin Oncol. 1994. PMID: 7992076 No abstract available.

6

Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.

Wangberg B, Forssell-Aronsson E, Tisell LE, Nilsson O, Fjalling M, Ahlman H. Wangberg B, et al. Br J Cancer. 1996 Mar;73(6):770-5. doi: 10.1038/bjc.1996.134. Br J Cancer. 1996. PMID: 8611378 Free PMC article. Clinical Trial.

7

Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome.

Fjälling M, Andersson P, Forssell-Aronsson E, Grétarsdóttir J, Johansson V, Tisell LE, Wängberg B, Nilsson O, Berg G, Michanek A, Lindstedt G, Ahlman H. Fjälling M, et al. J Nucl Med. 1996 Sep;37(9):1519-21. J Nucl Med. 1996. PMID: 8790206 Free article.

8

Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide.

Andersson P, Forssell-Aronsson E, Johanson V, Wängberg B, Nilsson O, Fjälling M, Ahlman H. Andersson P, et al. J Nucl Med. 1996 Dec;37(12):2002-6. J Nucl Med. 1996. PMID: 8970523 Free article.

9

Somatostatin receptor scintigraphy in medullary thyroid carcinoma.

Tisell LE, Ahlman H, Wängberg B, Hansson G, Mölne J, Nilsson O, Lindstedt G, Fjälling M, Forssell-Aronsson E. Tisell LE, et al. Br J Surg. 1997 Apr;84(4):543-7. Br J Surg. 1997. PMID: 9112914

10

Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.

Nilsson O, Kölby L, Wängberg B, Wigander A, Billig H, William-Olsson L, Fjälling M, Forssell-Aronsson E, Ahlman H. Nilsson O, et al. Br J Cancer. 1998 Feb;77(4):632-7. doi: 10.1038/bjc.1998.101. Br J Cancer. 1998. PMID: 9484822 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters